GT Biopharma, Inc. (GTBP)
NASDAQ·Healthcare·Biotechnology
$0.28
+0.61%
Mkt Cap $4.54M
No analyst coverage available
We don't have analyst ratings or price target data for GT Biopharma, Inc. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.